Delivery Order SPE2DB22D3004-SPE2DB25FSE50
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,727.74 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract, designated as a firm fixed-price delivery order with no set-aside designation, was competitively awarded on August 27, 2025, with an ultimate completion date of August 28, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order...
- The Defense Logistics Agency awarded a delivery order valued at $4,540.44 to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This firm fixed-price delivery order represents a non-competitive award issued under an existing contract vehicle and is scheduled for completion by August 21, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its...
- The Defense Logistics Agency awarded a $19,727.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of September 4, 2025. This non-competitive delivery order, issued on September 3, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion through December 2026. The pharmaceutical product will be delivered...
- The Defense Logistics Agency has awarded a delivery order valued at $9,104.70 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The primary contractor,...
- The Defense Logistics Agency awarded a delivery order valued at $10,440.68 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract, awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a firm fixed price delivery order with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency awarded a $1,041.42 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of July 30, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors, valued at $25,960.48. This firm fixed price delivery order represents a non-competitive, non-set-aside award and carries an ultimate completion date of August 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,522.48 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order, awarded on August 27, 2025, represents a non-competitive, non-set-aside award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $9,735.80 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract is firm fixed price with no set-aside designation and is scheduled for completion by August 25, 2025. AmerisourceBergen will perform work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $16,906.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract, which is not set-aside, was awarded on August 18, 2025, with an ultimate completion date of August 19, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSE50Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,719.57 to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This firm fixed-price delivery order, with an ultimate completion date of August 28, 2025, represents a competitive award with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the supply of a broad range of medications and medical supplies to support military healthcare programs worldwide. Repatha (evolocumab) is a PCSK9 inhibitor indicated for the treatment of high cholesterol and cardiovascular disease prevention, representing a specialized pharmaceutical product within the Defense Health Agency's medical supply portfolio. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated substantial capacity to fulfill federal medical procurement requirements through multiple competitively awarded contracts with DLA, supplying everything from brand-name specialty medications to generic drugs and medical devices across multiple therapeutic domains. This delivery order reflects the company's ongoing role as a critical vendor supporting military and veteran healthcare systems through the DLA's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 8/27/25 |